 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune...

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm PR Newswire NEW YORK, April 11, 2024 NEW YORK...

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN PR Newswire NEW YORK, April 11, 2024 NEW YORK...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN

Justin Sullivan / Staff / Getty Images

 Key TakeawaysU.S. equities were mixed at midday Thursday, April 11, 2024 as the latest report on inflation showed wholesale prices rose less than expected...

Top Stock Movers Now: Nike, Constellation Brands, Fastenal, and More

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday.
Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday's session.
read more...

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

News of the day for April 11, 2024

 Michael M. Santiago / Getty Images

U.S. stock futures are edging lower in premarket trading after tumbling Wednesday on the back of a hotter-than-forecast...

5 Things to Know Before the Stock Market Opens

Deal Values Each Alpine Share at a 38% Premium to Wednesday's Closing Price

 Source: TradingView.com

 Key TakeawaysVertex shares slipped in extended trading Wednesday after the company...

Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B Key Level to Watch

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8...

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today

Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex Shareholder Alert: Ademi LLP investigates whether Alpine Immune...

Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Alpine Immune Sciences, Inc. (NASDAQ: ALPN) to Vertex Pharmaceuticals Incorporated for $65.00 per share is fair to...

ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.

Volume (M)	2.49M
52-Wk High	$64.57
52-Wk Low	$6.71

ALPN Alpine Immune Sciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals